How can cannabinoid therapies be adapted for use in end-of-life care settings?
How can cannabinoid therapies be adapted for use in end-of-life care settings? Cannabinoid therapies can be adapted for use in end-of-life care settings by focusing on symptom management, improving quality of life, and addressing specific needs of terminally ill patients. Tailoring cannabinoid formulations to alleviate pain, nausea, and anxiety can provide significant relief and enhance comfort for patients in palliative care. Additionally, considering individual patient preferences and incorporating cannabinoid therapies into a holistic care plan can foster better communication and decision-making among healthcare providers and families. Training healthcare professionals to understand the therapeutic potential and safe use of cannabinoids is essential to optimize care in end-of-life settings. By integrating cannabinoid therapies thoughtfully, healthcare providers can enhance patient experiences and support family dynamics during this critical time (Aso et al., 2021).